Development of high throughput screening systems for the efficient production of antibody fragments in Escherichia coli
Recombinant antibodies and antibody fragments have become powerful tools for therapy, in vivo and in vitro diagnostics, and laboratory research. However, the production of antibody fragments in high yield for preclinical and clinical trials can be a serious bottleneck in drug discovery. This dissert...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/17756 |